
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 9.230 | 9.330 | 0.100 |
Shares | 92.330 | 92.330 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.309 | 17.901 |
Price to Book | 3.032 | 2.969 |
Price to Sales | 2.187 | 2.199 |
Price to Cash Flow | 13.284 | 11.852 |
Dividend Yield | 2.095 | 2.077 |
5 Years Earnings Growth | 9.636 | 10.075 |
Name | Net % | Category Average |
---|---|---|
Technology | 22.130 | 23.529 |
Healthcare | 14.320 | 12.932 |
Financial Services | 14.240 | 16.945 |
Consumer Cyclical | 13.490 | 10.485 |
Industrials | 13.180 | 11.820 |
Basic Materials | 8.980 | 3.984 |
Communication Services | 7.280 | 7.932 |
Utilities | 3.530 | 2.583 |
Consumer Defensive | 2.480 | 7.530 |
Real Estate | 0.190 | 2.760 |
Energy | 0.180 | 3.478 |
Number of long holdings: 86
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
db x-trackers JPX-Nikkei 400 DR 3C | IE00BRB36B93 | 4.02 | 29.44 | +1.06% | |
Netflix | US64110L1061 | 2.20 | 1,241.47 | -0.72% | |
Microsoft | US5949181045 | 1.92 | 470.38 | +0.58% | |
Costco | US22160K1051 | 1.90 | 1,014.94 | +0.41% | |
Eli Lilly | US5324571083 | 1.89 | 769.88 | +0.55% | |
Alphabet C | US02079K1079 | 1.83 | 174.92 | +3.01% | |
Apple | US0378331005 | 1.83 | 203.92 | +1.64% | |
Intesa Sanpaolo | IT0000072618 | 1.83 | 5.0200 | +1.46% | |
Visa A | US92826C8394 | 1.79 | 370.22 | +0.94% | |
Iberdrola | ES0144580Y14 | 1.78 | 16.010 | +0.25% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PTYESALM0007 | 56.7M | 1.40 | 0.62 | 1.92 | ||
PTYESYLM0009 | 55.01M | 19.49 | 11.15 | 4.30 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review